Immunization uptake in younger siblings of children with autism spectrum disorder

Ghassan Abu Kuwaik1, Wendy Roberts, Lonnie Zwaigenbaum

  • 11University of Toronto, Canada.

Insights

Parents of children with autism spectrum disorder (ASD) may delay or decline immunizations for younger siblings. This hesitancy increases the risk of preventable infectious diseases in these children.

Area of Science:

  • Pediatric Health
  • Immunology
  • Neurodevelopmental Disorders

Background:

  • Parental concerns link immunizations to autism spectrum disorder (ASD) risk.
  • This fear may lead to lower vaccination rates in younger siblings of children with ASD.

Purpose of the Study:

  • To compare immunization uptake in younger siblings versus their older siblings diagnosed with ASD (probands) and controls.
  • To investigate parental decisions regarding childhood immunizations in families with a history of ASD.

Main Methods:

  • Retrospective study analyzing immunization status.
  • Involved 98 younger siblings, 98 probands with ASD, and 65 controls.
  • Data collected on delayed or declined immunizations.

Main Results:

  • Significant differences in overall immunization status were observed (p < .001).
  • 48% of younger siblings had delayed and 12.2% declined immunizations.
  • Controls were fully immunized; probands had lower rates than controls, and younger siblings had the lowest rates.

Conclusions:

  • Parents with a child diagnosed with ASD may delay or refuse immunizations for subsequent children.
  • This hesitancy poses a significant risk for younger siblings contracting preventable infectious diseases.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...